Pharmacies can’t discriminate on reproductive health scripts

The Biden administration is warning pharmacies not to discriminate against women who may seek reproductive health prescriptions, including some that might be involved in ending a pregnancy.

The Department of Health and Human Services said Wednesday that pharmacies receiving federal money from programs such as Medicare and Medicaid cannot discriminate in how they supply medications or advise patients on prescriptions.

The agency noted that discrimination against people based on their pregnancy or related conditions would be a form of sex discrimination.

On Monday, the administration told hospitals that they “must” provide abortion services if the life of the mother is at risk. The government said federal law on emergency treatment guidelines preempts state laws in jurisdictions that now ban the procedure without any exceptions. Now, all states provide an exception for the life of the mother.

President Joe Biden also has signed an executive order to try to protect some access to the procedure, but he also has acknowledged that his administration is limited in what it can do. He noted earlier this month that an act of Congress would be required to restore nationwide access to abortion services, and he has urged Americans angered by the Supreme Court’s ruling to vote in November.

The department’s guidance to pharmacies outlined several hypothetical examples of potential discrimination. They include a pharmacy that refuses to fill a prescription of mifepristone followed by misoprostol to help manage complications from a miscarriage after a pregnancy loss.

That combination of drugs also is commonly used in medication abortions.

A pharmacy that refuses to fill a prescription of misoprostol prescribed to help deal with severe stomach ulcer complications may be discriminating based on disability, HHS said. The agency noted that the pharmacy also may be discriminating if it refuses to stock the drug based on its alternate use.